Kingson Lin

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Escherichia Coli

Oxidative Stress

Top Venues

Journal of the American Chemical Society

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Eric D Huseman, Anna Lo, Olga Fedorova, James L Elia, Susan E Gueble, Kingson Lin, Ranjini K Sundaram, Joonseok Oh, Jinchan Liu, Fabian S Menges, Matthew G Rees, Melissa M Ronan, Jennifer A Roth, Victor S Batista, Jason M Crawford, Anna Marie Pyle, Ranjit S Bindra, Seth B Herzon
Mechanism of Action of KL-50, a Candidate Imidazotetrazine for the Treatment of Drug-Resistant Brain Cancers. Journal of the American Chemical Society (2024)
Eric D Huseman, Anna Lo, Olga Fedorova, James L Elia, Susan E Gueble, Kingson Lin, Ranjini K Sundaram, Joonseok Oh, Jinchan Liu, Fabian S Menges, Matthew G Rees, Melissa M Ronan, Jennifer A Roth, Victor S Batista, Jason M Crawford, Anna Marie Pyle, Ranjit S Bindra, Seth B Herzon
Mechanism of Action of KL-50, a Candidate Imidazotetrazine for the Treatment of Drug-Resistant Brain Cancers. Journal of the American Chemical Society (2024)
Eric D Huseman, Anna Lo, Olga Fedorova, James L Elia, Susan E Gueble, Kingson Lin, Ranjini K Sundaram, Joonseok Oh, Jinchan Liu, Fabian S Menges, Matthew G Rees, Melissa M Ronan, Jennifer A Roth, Victor S Batista, Jason M Crawford, Anna Marie Pyle, Ranjit S Bindra, Seth B Herzon
Mechanism of Action of KL-50, a Candidate Imidazotetrazine for the Treatment of Drug-Resistant Brain Cancers. Journal of the American Chemical Society 146 (27) (2024)
Kingson Lin, Susan E Gueble, Ranjini K Sundaram, Eric D Huseman, Ranjit S Bindra, Seth B Herzon
Mechanism-based design of agents that selectively target drug-resistant glioma. Science (New York, N.Y.) 377 (6605) (2022)